Search Results

Patients with porphyria bask in sunlight of FDA approval.

• Authors : Ratner M; Tequesta, FL, USA.

Subjects: Dermatologic Agents/Dermatologic Agents/Dermatologic Agents/*therapeutic use ; Enzyme Inhibitors/Enzyme Inhibitors/Enzyme Inhibitors/*therapeutic use ; Porphyria, Acute Intermittent/Porphyria, Acute Intermittent/Porphyria, Acute Intermittent/*drug therapy

• Source: Nature biotechnology [Nat Biotechnol] 2019 Dec; Vol. 37 (12), pp. 1390-1391.Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Texas Tech University Health Sciences Center Researcher Reports on Findings in Acute Intermittent Porphyria (Acute Intermittent Porphyria in a Burn Patient: Case Study and Review of the Literature)

• Source: Obesity, Fitness & Wellness Week. April 27, 2024, 729

Record details

["Acute intermittent porphyria" diagnosis. An odyssey in diagnosis].

Subjects: Porphyria, Acute Intermittent/Porphyria, Acute Intermittent/Porphyria, Acute Intermittent/*diagnosis; Abdominal Pain/Abdominal Pain/Abdominal Pain/etiology ; Arginine/Arginine/Arginine/therapeutic use

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2002 May 23; Vol. 144 (21), pp. 56.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print ISSN: 1438-3276 (Print)

Record details

Al-Azhar University Researchers Publish Findings in Acute Intermittent Porphyria (Acute Intermittent Porphyria as a Rare Challenging Neuro-Metabolic Disease; a Case Report)

• Source: Obesity, Fitness & Wellness Week. October 1, 2022, 1205

Record details

Research from Second Hospital of Hebei Medical University Reveals New Findings on Acute Intermittent Porphyria (Acute intermittent porphyria: focus on possible mechanisms of acute and chronic manifestations)

• Source: Obesity, Fitness & Wellness Week. November 21, 2020, 4924

Record details

Recent Findings from School of Medicine Provides New Insights into Acute Intermittent Porphyria (Acute Intermittent Porphyria: Predicted Pathogenicity of HMBS Variants Indicates Extremely Low Penetrance of the Autosomal Dominant Disease)

• Source: Obesity, Fitness & Wellness Week. November 19, 2016, 1040

Record details

Shanxi Medical University Researchers Target Acute Intermittent Porphyria (Acute intermittent porphyria: a disease with low penetrance and high heterogeneity).

Subjects: ACUTE intermittent porphyria; MEDICAL research personnel; INBORN errors of metabolism

• Source: Gastroenterology Week; 8/27/2024, p743-743, 1p

Record details

Dipyrone/Phenylbutazone: Lack of efficacy: case report.

Subjects: *ACUTE intermittent porphyria; *DIPYRONE; *PHENYLBUTAZONE

• Source: Reactions Weekly. Dec2024, Vol. 2038 Issue 1, p117-117. 1p.

Record details

Bromocriptine/Erythromycin: Acute intermittent porphyria: case report.

Subjects: *ACUTE intermittent porphyria; *MOTOR neuron diseases; *OXYGEN saturation

• Source: Reactions Weekly. Dec2024, Vol. 2038 Issue 1, p65-65. 1p.

Record details

Sodium chloride: No improvement: case report.

Subjects: *INAPPROPRIATE ADH syndrome; *ACUTE intermittent porphyria; *SALT

• Source: Reactions Weekly. Nov2024, Vol. 2036 Issue 1, p436-436. 1p.

Record details